Healthcare Triangle, Inc.
HCTINasdaqCIK 1839285TechnologyFiscal year ends Dec 31
Reports and events: 118 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2317:20 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-112193 |
| 2026-10-1317:20 ET | DEF 14A | Proxy statementPeriod 2026-10-23 | 0001213900-26-109104 |
| 2026-10-0217:20 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-26-106533 |
| 2026-09-2517:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-103604 |
| 2026-09-0813:56 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-097953 |
| 2026-08-1317:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-089241 |
| 2026-07-2907:10 ET | 8-K | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-082514 |
| 2026-07-2016:05 ET | 8-K | 5.07 Shareholder vote results | 0001213900-26-079616 |
| 2026-07-1017:15 ET | S-1 | Registration statement | 0001213900-26-077268 |
| 2026-06-2617:00 ET | DEF 14A | Proxy statementPeriod 2026-07-17 | 0001213900-26-072691 |
| 2026-06-2616:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-072674 |
| 2026-06-1517:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-068871 |
| 2026-05-1420:19 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-056096 |
| 2026-04-1616:47 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001213900-26-044671 |
| 2026-04-1516:23 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-044078 |
| 2026-04-1017:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-042597 |
| 2026-04-0717:05 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001213900-26-041119 |
| 2026-03-1116:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-026181 |
| 2026-02-2717:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-021740 |
| 2026-02-1316:01 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-016390 |
| 2026-02-0616:01 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-013262 |
| 2026-01-2810:03 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-008594 |
| 2026-01-2010:26 ET | DEF 14A | Proxy statementPeriod 2026-02-02 | 0001213900-26-005400 |
| 2025-12-1009:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-119878 |
| 2025-12-0216:10 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-117252 |
| 2025-11-2116:57 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-113672 |
| 2025-11-1914:27 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-112546 |
| 2025-11-1709:43 ET | DEF 14A | Proxy statementPeriod 2025-11-28 | 0001213900-25-111526 |
| 2025-11-1308:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-109581 |
| 2025-11-1016:01 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-108196 |
| 2025-10-1516:01 ET | DEF 14A | Proxy statementPeriod 2025-11-07 | 0001213900-25-099128 |
| 2025-10-0817:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-097464 |
| 2025-09-1517:00 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-087694 |
| 2025-09-0217:52 ET | 8-K/A | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-082708 |
| 2025-08-1416:18 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-076686 |
| 2025-08-0117:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-070705 |
| 2025-07-0709:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-061649 |
| 2025-06-2317:13 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-056774 |
| 2025-05-3017:26 ET | 8-K | 3.01 Delisting notice | 0001213900-25-049571 |
| 2025-05-2317:11 ET | 8-K | 3.01 Delisting notice | 0001213900-25-047425 |
| 2025-05-2016:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-045994 |
| 2025-05-0921:33 ET | S-1/A | Registration statement, amended | 0001213900-25-041190 |
| 2025-04-2216:57 ET | S-1/A | Registration statement, amended | 0001213900-25-034248 |
| 2025-04-1117:29 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-031182 |
| 2025-04-1108:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-030806 |
| 2025-04-0216:01 ET | 8-K | 5.07 Shareholder vote results | 0001213900-25-027987 |
| 2025-04-0111:40 ET | S-1 | Registration statement | 0001213900-25-027277 |
| 2025-03-3116:01 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-026218 |
| 2025-03-2416:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001013762-25-001582 |
| 2025-03-0707:00 ET | DEF 14A | Proxy statementPeriod 2025-03-28 | 0001213900-25-021346 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:16 ET. Listed shows no prices and gives no investment advice.